Aimed Bio (A0009K0) Stock Overview
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
A0009K0 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Aimed Bio Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩27,200.00 |
| 52 Week High | ₩80,200.00 |
| 52 Week Low | ₩23,000.00 |
| Beta | 0 |
| 1 Month Change | -30.79% |
| 3 Month Change | -57.70% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -38.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| A0009K0 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 2.6% | -1.9% | -0.3% |
| 1Y | n/a | 10.9% | 165.0% |
Return vs Industry: Insufficient data to determine how A0009K0 performed against the KR Biotechs industry.
Return vs Market: Insufficient data to determine how A0009K0 performed against the KR Market.
Price Volatility
| A0009K0 volatility | |
|---|---|
| A0009K0 Average Weekly Movement | 11.8% |
| Biotechs Industry Average Movement | 10.7% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in KR Market | 16.2% |
| 10% least volatile stocks in KR Market | 4.5% |
Stable Share Price: A0009K0 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A0009K0's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Nam-Gu Her | www.aimedbio.com |
Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea.
Aimed Bio Inc. Fundamentals Summary
| A0009K0 fundamental statistics | |
|---|---|
| Market cap | ₩1.76t |
| Earnings (TTM) | ₩4.07b |
| Revenue (TTM) | ₩54.20b |
Is A0009K0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A0009K0 income statement (TTM) | |
|---|---|
| Revenue | ₩54.20b |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩54.20b |
| Other Expenses | ₩50.12b |
| Earnings | ₩4.07b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 62.99 |
| Gross Margin | 100.00% |
| Net Profit Margin | 7.52% |
| Debt/Equity Ratio | 0% |
How did A0009K0 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/14 23:10 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aimed Bio Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Keunhee Seo | Samsung Securities Co. Ltd. |